May 29, 2025

Long-Term Steroids in COPD Raise Health Risks

A study of over 500,000 patients found that using inhaled corticosteroids for more than 2 years in COPD significantly increased the risk of diabetes, pneumonia, fractures, cataracts, and osteoporosis.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 28, 2025

Study Finds Low RSV Vaccine Uptake Among Older Adults

A new multicenter analysis of over 6,700 hospitalized older adults found that RSV vaccine uptake was low in its first season, with significant gaps in awareness and access, especially among socioeconomically vulnerable populations.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 20, 2025

ICU Sedation Economics: A $1 Difference

Study finds dexmedetomidine, clonidine, and propofol have comparable cost-effectiveness for critically ill patients on mechanical ventilation.

Conexiant

October 29, 2024

New Data Challenges Pediatric Sinusitis Treatment Guidelines

A JAMA review revealed that only 26% of pediatric ABRS patients treated with placebo required subsequent antibiotic therapy, prompting questions about current guidelines recommending first-line antibiotic use in children with sinusitis.

Conexiant

November 01, 2024

Are Antibiotics Needed for Pediatric Pneumonia?

Nearly one in five children diagnosed with pneumonia in outpatient settings did not receive antibiotics, according to a recent study in JAMA Network Open.

Conexiant

July 02, 2024

Black Docs Lacking Amid Growing Attacks on Diversity Programs

Research has shown that patients of color prefer seeing doctors of their own race — and some studies have shown health outcomes are better for Black patients seeing Black doctors.

KFF Health News

December 13, 2024

New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Conexiant